55 studies found for:    "fragile x syndrome"
Show Display Options
Rank Status Study
21 Completed A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: MG01CI extended-release tablet
22 Completed Riluzole in Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: Riluzole
23 Completed An Open-Label Trial of Donepezil in Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: donepezil
24 Completed
Has Results
Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: Minocycline
25 Unknown  Teaching Math Skills to Individuals With Fragile X Syndrome
Conditions: Developmental Disabilities;   Fragile X Syndrome
Intervention: Behavioral: discrete-trial training
26 Completed
Has Results
Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: placebo;   Drug: oxytocin 24IU;   Drug: oxytocin 48IU
27 Recruiting Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome
Conditions: Fragile X Syndrome;   Intellectual Disability
Intervention: Behavioral: Social gaze training
28 Completed A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: NNZ-2566;   Drug: Placebo
29 Completed
Has Results
Randomized Controlled Study of Donepezil in Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: donepezil;   Drug: sugar pill
30 Terminated An Open Label Extension Study in Subjects With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: arbaclofen
31 Completed A Study of RO4917523 in Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: Placebo;   Drug: RO4917523 0.5 mg;   Drug: RO4917523 1.5 mg
32 Completed A Study With RO4917523 in Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: Placebo (for RO4917523 ascending doses);   Drug: Placebo (for RO4917523 fixed dose);   Drug: RO4917523
33 Completed A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: Placebo;   Drug: RO4917523
34 Suspended A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: STX107
35 Completed Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen;   Drug: Placebo
36 Completed Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: NPL-2009
37 Recruiting The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone
38 Completed Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
Condition: Fragile X Syndrome
Intervention: Drug: STX209
39 Completed Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients
Condition: Fragile X Syndrome
Interventions: Drug: AF056;   Drug: Placebo
40 Recruiting Cognitive Training for Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Other: Working Memory Training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-55) Show next page of results    Last Page
Indicates status has not been verified in more than two years